• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
micromobility.com Inc. - Class A Common Stock
Edit Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

State Street SPDR S&P Biotech ETF (NY:XBI)

140.18 -3.94 (-2.73%)
Official Closing Price Updated: 8:00 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,438,406
Open 142.88
Bid (Size) 140.55 (1,000)
Ask (Size) 141.32 (500)
Prev. Close 144.12
Today's Range 139.87 - 145.50
52wk Range 113.57 - 169.89
Shares Outstanding 541,500
Dividend Yield 0.20%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
IYH and XBI: Two Distinct Paths to Investing in Healthcare ↗
November 07, 2026
XBI delivered stronger 1-year returns at 45%, but IYH's diversified portfolio weathered volatility far better, with a maximum drawdown of just 17.9% versus 53.2%. 
Via The Motley Fool
Topics ETFs
News headline image
Decoding Healthcare ETFs: Different Sectors, Different Strategies ↗
November 07, 2026
RSPH offers broader sector diversification with lower volatility, while XBI delivers higher short-term gains but with steeper drawdowns. 
Via The Motley Fool
Topics ETFs

Performance

52-Week Range 17.5% below 52-week high
140.18
113.5752W Low 169.8952W High
1 Week 7.4% below 1-week high
139.871W Low 151.341W High

State Street SPDR S&P Biotech ETF (XBI) traded between $113.57 and $169.89 over the past 52 weeks and last traded at $140.18, 17.5% below its 52-week high. Over the past week it ranged between $139.87 and $151.34.

Past 12 Months
-3.9%
-8.2%
-15.4%
+6.5%
+15.4%
+23.1%
1W -$5.70
1M -$12.60
3M -$25.55
6M +$8.52
YTD +$18.66
1Y +$26.35

XBI was +23.1% over the past year, +6.5% over six months, +15.4% year to date, -3.9% in the last week.

12 Months vs Market
XBI
+23.1%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months XBI returned +23.1% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 1.04× 3-mo avg
Today 9,438,406 3-mo avg 9.1M
1W
9.3M
1M
8.9M
3M
9.1M
6M
9.0M
YTD
9.2M
1Y
9.2M

XBI most recently traded 9,438,406 shares against a 3-month average daily volume of 9.1M.

More News

Read More
News headline image
Biotech Giants vs. Emerging Innovators: Which ETF Is the Better Buy? ↗
October 22, 2026
Via The Motley Fool
Topics ETFs
News headline image
Better Healthcare ETF: Fidelity's Broad, Low-Cost FHLC vs. State Street's XBI Targeting Biotech ↗
October 05, 2026
Via The Motley Fool
Topics ETFs
News headline image
Better State Street Healthcare ETF: XBI's Biotech Focus vs. XPH Targeting Pharmaceuticals ↗
October 04, 2026
Via The Motley Fool
Topics ETFs
News headline image
VHT vs. XBI: Is Diversified Healthcare Exposure or Biotech Stocks the Smarter Choice for Investors? ↗
September 22, 2026
Via The Motley Fool
Topics ETFs
News headline image
Breakfast News: A Conversation With Ionis CEO ↗
August 22, 2026
Via The Motley Fool
Topics ETFs World Trade
News headline image
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? ↗
August 20, 2026
Via The Motley Fool
Topics ETFs
News headline image
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? ↗
August 19, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? ↗
August 18, 2026
Via The Motley Fool
Topics ETFs
News headline image
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? ↗
August 08, 2026
Via The Motley Fool
Topics ETFs
News headline image
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? ↗
August 03, 2026
Via The Motley Fool
Topics ETFs
News headline image
Here's How Much $100 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth Today ↗
July 13, 2026
Via Benzinga
Topics ETFs Stocks
News headline image
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗
July 09, 2026
Via The Motley Fool
Topics ETFs
News headline image
Fidelity Health Care vs. State Street Biotech: Which ETF Fits Your Portfolio Best? ↗
July 05, 2026
Via The Motley Fool
Topics ETFs
News headline image
The Best Biotech Stocks to Buy in 2026 ↗
June 17, 2026
Via The Motley Fool
Topics ETFs
News headline image
Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? ↗
June 17, 2026
Via The Motley Fool
Topics ETFs
News headline image
3 Longevity ETFs to Buy and Hold (and Hold) ↗
June 08, 2026
Via MarketBeat
Topics Artificial Intelligence ETFs
News headline image
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗
June 05, 2026
Via The Motley Fool
Topics ETFs
News headline image
VHT vs. XBI: Vanguard Health Care ETF Tops SPDR Biotech in Yield and Cost ↗
May 28, 2026
Via The Motley Fool
Topics ETFs
News headline image
2 Ways to Play the Big Pharma Patent Cliff ↗
May 15, 2026
Via MarketBeat
Topics ETFs Intellectual Property
News headline image
Small Caps Under Siege: Russell 2000 Enters Correction as Yields Surge
March 23, 2026
Via MarketMinute
Topics Bonds ETFs Economy
News headline image
DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing ↗
March 21, 2026
Via The Motley Fool
Topics Derivatives ETFs Regulatory Compliance
News headline image
IBRX Stock Rises Overnight: Retail Bets Anktiva’s NCCN 'Recommended' Tag Will Drive Prescriptions And Insurance Wins ↗
March 17, 2026
Via Stocktwits
Topics ETFs
News headline image
The Azetukalner Breakthrough: A Deep Dive into Xenon Pharmaceuticals (XENE)
March 12, 2026
Via Finterra
Topics ETFs Intellectual Property

Frequently Asked Questions

Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 140.18
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 11/20/26 08:00 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 75.91M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 76M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap